The devices, currently being investigated by teams of heart specialists, could make a big impact in the years ahead. 

With physician burnout on the rise and a massive physician shortage on the way, it’s more important now than ever to keep a close eye on how the country’s cardiologists—and their colleagues—are being paid. 

“We believe this case is potentially groundbreaking," one interventional cardiologist said. 

Transcaval TAVR was linked to a much lower stroke rate and fewer bleeding complications. 

“Our results are relevant to clinical practice, supporting the use of the Mediterranean diet in secondary prevention," researchers wrote. 

The medication failed a routine dissolution test, meaning it could lose its effectiveness. 

Kirk Garratt, MD, medical director of the Center for Heart and Vascular Health, ChristianaCare, and a past president of SCAI, explains what this shortage means for interventional cardiologists.

There have been five reported incidents so far, including one patient injury.